Literature DB >> 20729297

Large non-coding RNAs: missing links in cancer?

Maite Huarte1, John L Rinn.   

Abstract

Cellular homeostasis is achieved by the proper balance of regulatory networks that if disrupted can lead to cellular transformation. These cell circuits are fine-tuned and maintained by the coordinated function of proteins and non-coding RNAs (ncRNAs). In addition to the well-characterized protein coding and microRNAs constituents, large ncRNAs are also emerging as important regulatory molecules in tumor-suppressor and oncogenic pathways. Recent studies have revealed mechanistic insight of large ncRNAs regulating key cancer pathways at a transcriptional, post-transcriptional and epigenetic level. Here we synthesize these latest advances within the context of their mechanistic roles in regulating and maintaining cellular equilibrium. We posit that similar to protein-coding genes, large ncRNAs are a newly emerging class of oncogenic and tumor-suppressor genes. Our growing knowledge of the role of large ncRNAs in cellular transformation is pointing towards their potential use as biomarkers and targets for novel therapeutic approaches in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729297      PMCID: PMC2953740          DOI: 10.1093/hmg/ddq353

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  98 in total

1.  Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation.

Authors:  Radha Raman Pandey; Tanmoy Mondal; Faizaan Mohammad; Stefan Enroth; Lisa Redrup; Jan Komorowski; Takashi Nagano; Debora Mancini-Dinardo; Chandrasekhar Kanduri
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

2.  Non-coding RNA transcription: turning on neighbours.

Authors:  Piero Carninci
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

3.  Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.

Authors:  Roger Gejman; Dalia L Batista; Ying Zhong; Yunli Zhou; Xun Zhang; Brooke Swearingen; Constantine A Stratakis; E Tessa Hedley-Whyte; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2008-07-15       Impact factor: 5.958

4.  Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma.

Authors:  Leonidas Benetatos; Aggeliki Dasoula; Eleftheria Hatzimichael; Ioannis Georgiou; Maria Syrrou; Konstantinos L Bourantas
Journal:  Clin Lymphoma Myeloma       Date:  2008-06

Review 5.  Roles of the EZH2 histone methyltransferase in cancer epigenetics.

Authors:  Jeffrey A Simon; Carol A Lange
Journal:  Mutat Res       Date:  2008-08-03       Impact factor: 2.433

6.  Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome.

Authors:  Jing Zhao; Bryan K Sun; Jennifer A Erwin; Ji-Joon Song; Jeannie T Lee
Journal:  Science       Date:  2008-10-31       Impact factor: 47.728

7.  The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin.

Authors:  Takashi Nagano; Jennifer A Mitchell; Lionel A Sanz; Florian M Pauler; Anne C Ferguson-Smith; Robert Feil; Peter Fraser
Journal:  Science       Date:  2008-11-06       Impact factor: 47.728

8.  GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer.

Authors:  M Mourtada-Maarabouni; M R Pickard; V L Hedge; F Farzaneh; G T Williams
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

9.  Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation.

Authors:  Maria Corsignano Guastadisegni; Angelo Lonoce; Luciana Impera; Francesco Albano; Pietro D'Addabbo; Sebastiano Caruso; Isabella Vasta; Ioannis Panagopoulos; Anna Leszl; Giuseppe Basso; Mariano Rocchi; Clelia Tiziana Storlazzi
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

10.  Bidirectional transcription directs both transcriptional gene activation and suppression in human cells.

Authors:  Kevin V Morris; Sharon Santoso; Anne-Marie Turner; Chiara Pastori; Peter G Hawkins
Journal:  PLoS Genet       Date:  2008-11-14       Impact factor: 5.917

View more
  256 in total

Review 1.  Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go.

Authors:  Amy N Shore; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-03-09       Impact factor: 2.673

2.  The long noncoding RNA Vax2os1 controls the cell cycle progression of photoreceptor progenitors in the mouse retina.

Authors:  Nicola Meola; Mariateresa Pizzo; Giovanna Alfano; Enrico Maria Surace; Sandro Banfi
Journal:  RNA       Date:  2011-11-29       Impact factor: 4.942

Review 3.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 4.  LncRNAs: emerging players in gene regulation and disease pathogenesis.

Authors:  Mina Kazemzadeh; Reza Safaralizadeh; Ayla Valinezhad Orang
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

5.  Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.

Authors:  Bo Lei; Shou-Ping Xu; Xiao-Shuan Liang; Yi-Wen Li; Jin-Feng Zhang; Guo-Qiang Zhang; Da Pang
Journal:  Tumour Biol       Date:  2015-11-10

6.  Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.

Authors:  Jun Wang; Gong Cheng; Xiao Li; Yongsheng Pan; Chao Qin; Haiwei Yang; Lixin Hua; Zengjun Wang
Journal:  Tumour Biol       Date:  2016-01-21

Review 7.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis.

Authors:  H Wu; J Zheng; J Deng; L Zhang; N Li; W Li; F Li; J Lu; Y Zhou
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

Review 9.  Roles for MDC1 in cancer development and treatment.

Authors:  Sophie E Ruff; Susan K Logan; Michael J Garabedian; Tony T Huang
Journal:  DNA Repair (Amst)       Date:  2020-08-11

10.  LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX.

Authors:  Dafeng Xu; Xiangmei Liu; Jincai Wu; Yu Wang; Kailun Zhou; Wenmei Chen; Jiacheng Chen; Cheng Chen; Liang Chen
Journal:  Cancer Biol Ther       Date:  2020-09-15       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.